E-Cigarette Liquids for Cardiopulmonary Health
PR
Overseen ByPaula Rodriguez Miguelez, PhD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: Virginia Commonwealth University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the user's health. The overall goal of this study is to evaluate the impact of e-cigarettes usage on user's cardiopulmonary health
Research Team
PR
Paula Rodriguez Miguelez, PhD
Principal Investigator
Virginia Commonwealth University
Eligibility Criteria
This trial is for adults over the age of 21 who are either regular e-cigarette users (using them at least three times a week for more than three months) or those who have never used e-cigarettes. It's not specified, but typically people with certain health conditions may be excluded.Inclusion Criteria
I am 21 or older and do not use e-cigarettes.
I am 21 or older and have been using e-cigarettes regularly for at least 3 months.
Exclusion Criteria
Use of cigarettes for 15 days or more in the past 60 days
I have heart, lung, kidney, liver, metabolic, or brain diseases.
Use of marijuana or any illicit or prescription drugs for non-medical use weekly or more frequently in the past 60 days
See 5 more
Treatment Details
Interventions
- Tobacco flavored liquid type 1
- Tobacco flavored liquid type 2
Trial OverviewThe study is testing two types of tobacco-flavored liquids used in cartridge-based electronic cigarettes to see how they affect the heart and lungs of the users. Participants will use these liquids and their cardiopulmonary health will be monitored.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: E-cigarette liquid type 1Experimental Treatment1 Intervention
Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.
Group II: E-cigarettes liquid type 2Active Control1 Intervention
Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.
Group III: No e-cigarettesActive Control1 Intervention
No e-cigarette use
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
Trials
732
Recruited
22,900,000+
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.